Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) EBT Margin (2023)

Contineum Therapeutics has reported EBT Margin over the past 1 years, most recently at 84.59% for Q2 2023.

  • Quarterly results put EBT Margin at 84.59% for Q2 2023, changed N/A from a year ago — trailing twelve months through Mar 2024 was 39.15% (changed N/A YoY), and the annual figure for FY2023 was 46.34%, changed.
  • EBT Margin for Q2 2023 was 84.59% at Contineum Therapeutics, down from 5243.48% in the prior quarter.
  • Over the last five years, EBT Margin for CTNM hit a ceiling of 5243.48% in Q1 2023 and a floor of 84.59% in Q2 2023.